Polaryx Therapeutics, Inc. (PLYX) Operating income 2024–2025
Polaryx Therapeutics, Inc. (PLYX) annual operating income history from SEC filings — each fiscal year as reported.
-$7.8MFY2025 · since FY2024: -$4.4M → -$7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.8M | -79.7% |
| FY2024 | -$4.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PLYX financial trends
PLYX RevenuePLYX Net incomePLYX Net marginPLYX Gross profitPLYX Gross marginPLYX Operating marginPLYX Operating cash flowPLYX Free cash flowPLYX Capital expendituresPLYX Return on equityPLYX Stock buybacksPLYX Dividends paidPLYX Total assetsPLYX Total liabilitiesPLYX Shareholders’ equityPLYX overview →